Douglas Flora: Excited to be part of the discussion on how AI is revolutionizing cancer screening

Douglas Flora shared a post on LinkedIn:

“Excited to be part of this important discussion on how AI is revolutionizing cancer screening!

On September 23, AI in Precision Oncology is hosting a program for important discussions on how we can use AI tools to save lives today.

I’ll be joining an incredible panel with leaders like Drs. Lecia Sequist, Sunil Verma, and Robert Smith to talk about the real-world impact AI is having—from improving early detection and prioritizing high-risk individuals to addressing health disparities in low- and middle-income countries.

The bonus, we’ve got the inimitable ‘OncDoc’, Sanjay Juneja, M.D. moderating our discussion.

We’ll be diving into how AI can streamline cancer screening processes, improve outcomes, and save lives. Don’t miss out — register and join us!”

Source: Douglas Flora/LinkedIn

More posts featuring Douglas Flora on oncodaily.com

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.